Standard

A regimen of treatment for testicular germ cell cancer vs. tumor stage. / Gorelov, A. I.; Bogdanova, Ye O.; Komyakov, B. K.

в: Voprosy Onkologii, Том 49, № 4, 2003, стр. 455-458.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Gorelov, AI, Bogdanova, YO & Komyakov, BK 2003, 'A regimen of treatment for testicular germ cell cancer vs. tumor stage', Voprosy Onkologii, Том. 49, № 4, стр. 455-458.

APA

Gorelov, A. I., Bogdanova, Y. O., & Komyakov, B. K. (2003). A regimen of treatment for testicular germ cell cancer vs. tumor stage. Voprosy Onkologii, 49(4), 455-458.

Vancouver

Gorelov AI, Bogdanova YO, Komyakov BK. A regimen of treatment for testicular germ cell cancer vs. tumor stage. Voprosy Onkologii. 2003;49(4):455-458.

Author

Gorelov, A. I. ; Bogdanova, Ye O. ; Komyakov, B. K. / A regimen of treatment for testicular germ cell cancer vs. tumor stage. в: Voprosy Onkologii. 2003 ; Том 49, № 4. стр. 455-458.

BibTeX

@article{ae671559c33d4fb689f35930773f60f4,
title = "A regimen of treatment for testicular germ cell cancer vs. tumor stage",
abstract = "Complex examination and treatment were given to 282 patients with testicular germ cell cancer. Diagnosis was histologically verified in all cases. Metastases at different sites were identified in 136 (48.2%). Seminoma was treated with telegamma radiation from the ROCUS-M installation; cases of non-seminoma pathology received VAB-6 and BEP regimes. Germ cell cancer staging was facilitated by joint use of up-to-date diagnostic procedures. X-ray examination of organs of the chest was performed in all cases and sometimes supplemented with CT. Ultrasound, CT and MRI were chiefly used for diagnosis of pathologies of the abdominal cavity and retroperitoneal space. Prognosis and chemotherapy regimes were based on tumor stage assessment. After therapy, recurrence-free cases and those with total regression were released from hospital. Oncological follow-up included tumor marker monitoring and dynamic X-ray examination of the chest, abdominal cavity and retroperitoneal space. When metastasis regression was not complete, surgery was indicated, if technically feasible.",
author = "Gorelov, {A. I.} and Bogdanova, {Ye O.} and Komyakov, {B. K.}",
note = "Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",
year = "2003",
language = "русский",
volume = "49",
pages = "455--458",
journal = "Вопросы онкологии",
issn = "0507-3758",
publisher = "Медицина",
number = "4",

}

RIS

TY - JOUR

T1 - A regimen of treatment for testicular germ cell cancer vs. tumor stage

AU - Gorelov, A. I.

AU - Bogdanova, Ye O.

AU - Komyakov, B. K.

N1 - Copyright: Copyright 2009 Elsevier B.V., All rights reserved.

PY - 2003

Y1 - 2003

N2 - Complex examination and treatment were given to 282 patients with testicular germ cell cancer. Diagnosis was histologically verified in all cases. Metastases at different sites were identified in 136 (48.2%). Seminoma was treated with telegamma radiation from the ROCUS-M installation; cases of non-seminoma pathology received VAB-6 and BEP regimes. Germ cell cancer staging was facilitated by joint use of up-to-date diagnostic procedures. X-ray examination of organs of the chest was performed in all cases and sometimes supplemented with CT. Ultrasound, CT and MRI were chiefly used for diagnosis of pathologies of the abdominal cavity and retroperitoneal space. Prognosis and chemotherapy regimes were based on tumor stage assessment. After therapy, recurrence-free cases and those with total regression were released from hospital. Oncological follow-up included tumor marker monitoring and dynamic X-ray examination of the chest, abdominal cavity and retroperitoneal space. When metastasis regression was not complete, surgery was indicated, if technically feasible.

AB - Complex examination and treatment were given to 282 patients with testicular germ cell cancer. Diagnosis was histologically verified in all cases. Metastases at different sites were identified in 136 (48.2%). Seminoma was treated with telegamma radiation from the ROCUS-M installation; cases of non-seminoma pathology received VAB-6 and BEP regimes. Germ cell cancer staging was facilitated by joint use of up-to-date diagnostic procedures. X-ray examination of organs of the chest was performed in all cases and sometimes supplemented with CT. Ultrasound, CT and MRI were chiefly used for diagnosis of pathologies of the abdominal cavity and retroperitoneal space. Prognosis and chemotherapy regimes were based on tumor stage assessment. After therapy, recurrence-free cases and those with total regression were released from hospital. Oncological follow-up included tumor marker monitoring and dynamic X-ray examination of the chest, abdominal cavity and retroperitoneal space. When metastasis regression was not complete, surgery was indicated, if technically feasible.

UR - http://www.scopus.com/inward/record.url?scp=4444380343&partnerID=8YFLogxK

M3 - статья

C2 - 14569936

AN - SCOPUS:4444380343

VL - 49

SP - 455

EP - 458

JO - Вопросы онкологии

JF - Вопросы онкологии

SN - 0507-3758

IS - 4

ER -

ID: 74427873